WHO ICTRP trial
Treatment of lymphoma with targeted internal radiation therapy (Betalutin)
EUCTR2011-000033-36-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-000033-36-CZ |
|---|---|
| Public title | Treatment of lymphoma with targeted internal radiation therapy (Betalutin) |
| Scientific title | A phase I/II study of lutetium (177Lu)-lilotomab satetraxetan (Betalutin®) antibody-radionuclide-conjugate for treatment of relapsed non-Hodgkin lymphoma |
| Primary sponsor | Nordic Nanovector ASA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Finland;Spain;Ireland;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;European Union;Belgium;Croatia;Denmark;Australia;Netherlands;Germany;Sweden |
| Conditions | Non-Hodgkin B-cell lymphoma Part A: Relapsed indolent Non-Hodgkin B-cell lymphoma Part B: Relapsed follicular lymphoma Part C: Relapsed indolent Non-Hodgkin B-cell lymphoma MedDRA version: 22.0 Level: PT Classification code 10029547 Term… |
| Interventions | Product Name: Betalutin Product Code: Lutetium (177Lu)-lilotomab satetraxetan Pharmaceutical Form: Solution for injection INN or Proposed INN: Lutetium (177Lu)-lilotomab satetraxetan CAS Number: 1453362-90-7 Current Sponsor code… |
| Registration date | May 8, 2014 |
| Target size | 200 |
| Secondary IDs | LYMRIT-37-01;2011-000033-36-SE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: